SampleID | NumReplicates | Organism | TissueType | CellType | MHCAllele |
---|---|---|---|---|---|
SampleID | NumReplicates | Organism | TissueType | CellType | MHCAllele |
SYSMHC00061_F0713_THP1_BB72_Filter | 1 | Human | HLA-A02:01 | ||
SYSMHC00061_F0713_THP1_BB72_P | 10 | Human | HLA-A02:01 | ||
SYSMHC00061_F0713_THP1_w632_Filter | 1 | Human | HLA-A02:01,HLA-B27:05,HLA-B15:11,HLA-C03:03 | ||
SYSMHC00061_F0713_THP1_w632_P | 10 | Human | HLA-A02:01,HLA-B27:05,HLA-B15:11,HLA-C03:03 | ||
SYSMHC00061_F0817_THP1_BB72_Filter | 1 | Human | HLA-A02:01 | ||
SYSMHC00061_F0817_THP1_BB72_P | 10 | Human | HLA-A02:01 | ||
SYSMHC00061_F0817_THP1_w632_Filter | 1 | Human | HLA-A02:01,HLA-B27:05,HLA-B15:11,HLA-C03:03 | ||
SYSMHC00061_F0817_THP1_w632_P | 10 | Human | HLA-A02:01,HLA-B27:05,HLA-B15:11,HLA-C03:03 | ||
SYSMHC00061_F0830_THP1_BB72_Filter_TR | 3 | Human | HLA-A02:01 | ||
SYSMHC00061_F0830_THP1_BB72_P | 10 | Human | HLA-A02:01 | ||
SYSMHC00061_F0830_THP1_w632_Filter_TR | 3 | Human | HLA-A02:01,HLA-B27:05,HLA-B15:11,HLA-C03:03 | ||
SYSMHC00061_F0830_THP1_w632_P | 10 | Human | HLA-A02:01,HLA-B27:05,HLA-B15:11,HLA-C03:03 |
ID | SampleID | RawFileName | Organism | Process | Tissue Type | Cell Type | Culture Conditions | Disease State | Comments | MHCClass | MHCAllele | PubMed ID | Peptide | Isolation Method | Antibody | Mass Spectrometer | LC System | iRT Peptides | Acquisition Mode | Fragmentation Method | Gradient | Gradient Length | Flow Rate | Replicate Number |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ID | SampleID | RawFileName | Organism | Process | Tissue_Type | Cell_Type | Culture_Conditions | Disease_State | Comments | MHCClass | MHCAllele | PubMed_ID | Peptide | Isolation_Method | Antibody | Mass_Spectrometer | LC_System | iRT_Peptides | Acquisition_Mode | Fragmentation_Method | Gradient | Gradient_Length | Flow_Rate | Replicate_Number |
SYSMHC00061 | SYSMHC00061_F0830_THP1_BB72_P | F20180830_KP_THP1_BB72_P9.raw | Human | In vitro | Blood | Lymphoblast cell | suspension | EBV transformed | class I | HLA-A02:01 | 32387766 | native | Immunoaffinity | W6/32 | Orbitrap Fusion Lumos | RP-HPLC | no | DDA | HCD | 1 | ||||
SYSMHC00061 | SYSMHC00061_F0830_THP1_BB72_P | F20180830_KP_THP1_BB72_P8.raw | Human | In vitro | Blood | Lymphoblast cell | suspension | EBV transformed | class I | HLA-A02:01 | 32387766 | native | Immunoaffinity | W6/32 | Orbitrap Fusion Lumos | RP-HPLC | no | DDA | HCD | 2 | ||||
SYSMHC00061 | SYSMHC00061_F0830_THP1_BB72_P | F20180830_KP_THP1_BB72_P7.raw | Human | In vitro | Blood | Lymphoblast cell | suspension | EBV transformed | class I | HLA-A02:01 | 32387766 | native | Immunoaffinity | W6/32 | Orbitrap Fusion Lumos | RP-HPLC | no | DDA | HCD | 3 | ||||
SYSMHC00061 | SYSMHC00061_F0830_THP1_BB72_P | F20180830_KP_THP1_BB72_P6.raw | Human | In vitro | Blood | Lymphoblast cell | suspension | EBV transformed | class I | HLA-A02:01 | 32387766 | native | Immunoaffinity | W6/32 | Orbitrap Fusion Lumos | RP-HPLC | no | DDA | HCD | 4 | ||||
SYSMHC00061 | SYSMHC00061_F0830_THP1_BB72_P | F20180830_KP_THP1_BB72_P5.raw | Human | In vitro | Blood | Lymphoblast cell | suspension | EBV transformed | class I | HLA-A02:01 | 32387766 | native | Immunoaffinity | W6/32 | Orbitrap Fusion Lumos | RP-HPLC | no | DDA | HCD | 5 | ||||
SYSMHC00061 | SYSMHC00061_F0830_THP1_BB72_P | F20180830_KP_THP1_BB72_P4.raw | Human | In vitro | Blood | Lymphoblast cell | suspension | EBV transformed | class I | HLA-A02:01 | 32387766 | native | Immunoaffinity | W6/32 | Orbitrap Fusion Lumos | RP-HPLC | no | DDA | HCD | 6 | ||||
SYSMHC00061 | SYSMHC00061_F0830_THP1_BB72_P | F20180830_KP_THP1_BB72_P3.raw | Human | In vitro | Blood | Lymphoblast cell | suspension | EBV transformed | class I | HLA-A02:01 | 32387766 | native | Immunoaffinity | W6/32 | Orbitrap Fusion Lumos | RP-HPLC | no | DDA | HCD | 7 | ||||
SYSMHC00061 | SYSMHC00061_F0830_THP1_BB72_P | F20180830_KP_THP1_BB72_P2.raw | Human | In vitro | Blood | Lymphoblast cell | suspension | EBV transformed | class I | HLA-A02:01 | 32387766 | native | Immunoaffinity | W6/32 | Orbitrap Fusion Lumos | RP-HPLC | no | DDA | HCD | 8 | ||||
SYSMHC00061 | SYSMHC00061_F0830_THP1_BB72_P | F20180830_KP_THP1_BB72_P10.raw | Human | In vitro | Blood | Lymphoblast cell | suspension | EBV transformed | class I | HLA-A02:01 | 32387766 | native | Immunoaffinity | W6/32 | Orbitrap Fusion Lumos | RP-HPLC | no | DDA | HCD | 9 | ||||
SYSMHC00061 | SYSMHC00061_F0830_THP1_BB72_P | F20180830_KP_THP1_BB72_P1.raw | Human | In vitro | Blood | Lymphoblast cell | suspension | EBV transformed | class I | HLA-A02:01 | 32387766 | native | Immunoaffinity | W6/32 | Orbitrap Fusion Lumos | RP-HPLC | no | DDA | HCD | 10 |